Filtrer vos résultats
- 2
- 1
- 3
- 3
- 1
- 2
- 3
- 3
- 3
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
triés par
|
|
In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent.Haematologica, 2015, 100 (2), pp.223-30. ⟨10.3324/haematol.2014.111740⟩
Article dans une revue
inserm-01139861v1
|
||
|
Biological processes in solar lentigo: insights brought by experimental modelsExperimental Dermatology, 2016, 25 (3), pp.174-177. ⟨10.1111/exd.12937⟩
Article dans une revue
hal-02061445v1
|
||
Biological Description of 109 Cases of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) from the French Network of BPDCNBlood, 2015, 126 (23), pp.3812
Article dans une revue
hal-01290430v1
|